Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Sun Pharma ANZ Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (437)
Cancellation by sponsor (155)
Prescription medicine registration (28)
Section 14, TGO91 consent (5)
Australian public assessment report (AusPar) (4)
Prescription medicine decision summary (1)

Date

2025 (39)
2024 (47)
2023 (36)
2022 (54)
2021 (41)
2020 (25)
2019 (26)
2018 (50)
2017 (18)
2016 (35)
2015 (20)
2014 (10)
2013 (22)
2012 (62)
2011 (92)
2010 (14)
2009 (13)
2007 (12)
2006 (10)
2005 (3)

Search

Sponsor content

630 result(s) found, displaying 251 to 260

TOBRAMYCIN SUN tobramycin 300 mg/5 mL solution for inhalation ampoule (285709)

15 December 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TOBRAMYCIN SUN tobramycin 300 mg/5 mL solution for inhalation ampoule.
AusPAR: Ciclosporin

13 May 2020

Australian public assessment report (AusPar)

Australian Public Assessment Report for Ciclosporin
ODOMZO sonidegib diphosphate 200mg hard capsule bottle (292262)

17 October 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ODOMZO sonidegib diphosphate 200mg hard capsule bottle.
CEQUA (Sun Pharma ANZ Pty Ltd)

28 January 2020

Prescription medicine registration

Active ingredients: ciclosporin.
ULCAID ranitidine 150mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

1 November 2019

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
ULCAID ranitidine 300mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

1 November 2019

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
AusPAR: Tildrakizumab

4 October 2019

Australian public assessment report (AusPar)

Australian Public Assessment Report for Tildrakizumab
RANSIM simvastatin 10mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

31 July 2019

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
RANSIM simvastatin 80mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 July 2019

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
OCTREOTIDE SUN octreotide (as acetate) 500 microgram/1 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

27 June 2019

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd

Pages

First page
Previous page
…
Page 22
Page 23
Page 24
Page 25
Current page 26
Page 27
Page 28
Page 29
Page 30
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.